Yüklüyor......
A retrospective six-patient series of apatinib for the treatment of persistent or recurrent carcinoma of the cervix
OBJECTIVE: Although advances have been made in the clinical and therapeutic management of women with cervical cancer, the best treatment for patients with metastatic or recurrent cervical cancer is still undefined. Apatinib, a novel inhibitor of vascular endothelial growth factor receptor-2 tyrosine...
Kaydedildi:
| Yayımlandı: | Onco Targets Ther |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6643513/ https://ncbi.nlm.nih.gov/pubmed/31410025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S212536 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|